NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M

• "Our third quarter results fell short of our expectations" (CEO, President & Director Joel Becker), who reported "Total revenue in the third quarter was $23.1 million, including RNS System revenue of $22.9 million" and said the outcome "does not reflect the growth

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.